Glioma cells constitutively secrete C–C motif chemokine ligand 2 (CCL2), which converts Th2 lymphocytes into immunosuppressive T regulatory (Treg) cells and macrophages into the pro-neoplastic M2 phenotype [11]. This evidence concerns the gene CCL2 and glioma.